Clinical Trial Update: Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas [Phase 2]

View source ↗

Summary

Phase II trial of peginterferon alpha-2b plus thalidomide in adults with recurrent gliomas has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Peginterferon alpha-2b (pegylated interferon alfa-2b)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2011-10-26